Driver Bioengineering
San Francisco, US · Delaware corporation
Founders & leadership
WH
Wladimir HogenhuisNamed on SEC filing
BW
Benjamin WangNamed on SEC filing
SD
Scott DyllaNamed on SEC filing
GZ
Gusti ZeinerNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$23.2M disclosed across 1 round · 2019
▶$23.2MraisedFeb 2022 · 65 investors · BiotechnologyRule 506(b)
▶$23.2MraisedFeb 2022 · 65 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Wladimir HogenhuisExecutive Officer
- Benjamin WangDirector
- Scott DyllaDirector
- Gusti ZeinerDirector
- Offering amount
- $23.6M
- Amount sold
- $23.2M
- First sale
- May 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Driver Bioengineering raised?
- Driver Bioengineering has disclosed $23.2M raised across 1 round.
- Where is Driver Bioengineering headquartered?
- Driver Bioengineering is headquartered in San Francisco, US.